Literature DB >> 4976105

Immunochemical and serological studies of enzymaatically fragmented human IgG globulins. II. Hydrolysis with subtilisin, elastase, trypsin, and chymotrypsin.

M Waller, A J Richard, J Mallory.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4976105     DOI: 10.1016/0019-2791(69)90157-8

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  8 in total

1.  Immunoglobulin levels and auto-antibodies in normal healthy adults.

Authors:  A P Finch; C A Whelan; J de Azavedo; J F Greally
Journal:  Ir J Med Sci       Date:  1975-12       Impact factor: 1.568

2.  IgG hydrolysis in abscesses. II. Hydrolysis of Ripley IgG by enzymes from abscess leucocytes.

Authors:  M Waller
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

3.  The influence of infection on titres of antiglobulin antibodies.

Authors:  M Waller; R J Duma; E D Farley; J Atkinson
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

4.  Humoral responses in human organ transplantation.

Authors:  M Waller; J C Pierce; C W Moncure; D M Hume
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

5.  The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma.

Authors:  M Waller; J H Moon; R Irby; E C Toone
Journal:  Clin Exp Immunol       Date:  1971-01       Impact factor: 4.330

6.  Serum agglutinators in families with twins.

Authors:  M Waller; N Curry
Journal:  Immunology       Date:  1971-08       Impact factor: 7.397

7.  Naturally occurring human antibodies to the F(ab')2 portion of IgG.

Authors:  H Nasu; D S Chia; D W Knutson; E V Barnett
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

8.  Suppression of anti-erythrocyte autoantibody-producing B cells by a physiological IgG-anti-F(ab')2 antibody and escape from suppression by tumour transformation; a model relevant for the pathogenesis of autoimmune haemolytic anaemia.

Authors:  P Terness; U Marx; G Sandilands; D Roelcke; M Welschof; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.